Carregando...
Clinical Insights Into Novel Immune Checkpoint Inhibitors
The success of immune checkpoint inhibitors (ICIs), notably anti-cytotoxic T lymphocyte associated antigen-4 (CTLA-4) as well as inhibitors of CTLA-4, programmed death 1 (PD-1), and programmed death ligand-1 (PD-L1), has revolutionized treatment options for solid tumors. However, the lack of respons...
Na minha lista:
| Publicado no: | Front Pharmacol |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8139127/ https://ncbi.nlm.nih.gov/pubmed/34025438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.681320 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|